Medicinal chemistry principal target

Many commercially available and proprietary compound collections are synthesized in a combinatorial-type manner and so suffer from a lack of structural (principally scaffold) diversity [4, 11]. Another drawback of such collections stems from the nature of medicinal chemistry research over the course of the past few decades, which has focused upon a limited set of biological targets [7]. As a result, commercially available and proprietary compound Hbraries are... 

---